Search Results - "Bahra, M"

Pancreatogastrostomy Versus Pancreatojejunostomy for RECOnstruction After PANCreatoduodenectomy (RECOPANC, DRKS 00000767): Perioperative and Long-term Results of a Multicenter Randomized Controlled Trial by Keck, Tobias, Wellner, U F, Bahra, M, Klein, F, Sick, O, Niedergethmann, M, Wilhelm, T J, Farkas, S A, Börner, T, Bruns, C, Kleespies, A, Kleeff, J, Mihaljevic, A L, Uhl, W, Chromik, A, Fendrich, V, Heeger, K, Padberg, W, Hecker, A, Neumann, U P, Junge, K, Kalff, J C, Glowka, T R, Werner, J, Knebel, P, Piso, P, Mayr, M, Izbicki, J, Vashist, Y, Bronsert, P, Bruckner, T, Limprecht, R, Diener, M K, Rossion, I, Wegener, I, Hopt, U T

“…OBJECTIVES:To assess pancreatic fistula rate and secondary endpoints after pancreatogastrostomy (PG) versus pancreatojejunostomy (PJ) for reconstruction in…”
Get full text

α-Smooth muscle actin expression and desmoplastic stromal reaction in pancreatic cancer: results from the CONKO-001 study by Sinn, M, Denkert, C, Striefler, J K, Pelzer, U, Stieler, J M, Bahra, M, Lohneis, P, Dörken, B, Oettle, H, Riess, H, Sinn, B V

“…Background: Previous investigations in pancreatic cancer suggest a prognostic role for α -smooth muscle actin ( α -SMA) expression and stromal density in the…”
Get full text

Inorganic nitrate ingestion improves vascular compliance but does not alter flow-mediated dilatation in healthy volunteers by Bahra, M., Kapil, V., Pearl, V., Ghosh, S., Ahluwalia, A.

“…► Inorganic nitrate supplementation does not alter endothelial function in healthy volunteers. ► Despite this, there was a reduction in blood pressure and…”
Get full text

Hepatotoxicity following systemic therapy for colorectal liver metastases and the impact of chemotherapy-associated liver injury on outcomes after curative liver resection by Duwe, Gregor, MS, Knitter, Sebastian, MS, Pesthy, Sina, MS, Beierle, Anika S., MS, Bahra, Marcus, MD, Schmelzle, Moritz, MD, Schmuck, Rosa B., MD, Lohneis, Philipp, MD, Raschzok, Nathanael, MD, Öllinger, Robert, MD, Sinn, Marianne, MD, Struecker, Benjamin, MD, Sauer, Igor M., MD, Pratschke, Johann, MD, Andreou, Andreas, MD

“…ABSTRACT Patients with colorectal liver metastases (CLM) have remarkably benefited from the advances in medical multimodal treatment and surgical techniques…”
Get full text

CONKO-006: A randomised double-blinded phase IIb-study of additive therapy with gemcitabine + sorafenib/placebo in patients with R1 resection of pancreatic cancer – Final results by Sinn, M., Liersch, T., Riess, H., Gellert, K., Stübs, P., Waldschmidt, D., Lammert, F., Maschmeyer, G., Bechstein, W., Bitzer, M., Denzlinger, C., Hofheinz, R., Lindig, U., Ghadimi, M., Hinke, A., Striefler, J.K., Pelzer, U., Bischoff, S., Bahra, M., Oettle, H.

“…CONKO-006 was designed for patients with pancreatic adenocarcinoma with postsurgical R1 residual status to evaluate the efficacy and safety of the combination…”
Get full text

Mucosal-associated invariant T cells contribute to suppression of inflammatory myeloid cells in immune-mediated kidney disease by Gnirck, Ann-Christin, Philipp, Marie-Sophie, Waterhölter, Alex, Wunderlich, Malte, Shaikh, Nikhat, Adamiak, Virginia, Henneken, Lena, Kautz, Tobias, Xiong, Tingting, Klaus, Daniela, Tomczyk, Pascal, Al-Bahra, Mohamad M., Menche, Dirk, Walkenhorst, Mark, Lantz, Olivier, Willing, Anne, Friese, Manuel A., Huber, Tobias B., Krebs, Christian F., Panzer, Ulf, Kurts, Christian, Turner, Jan-Eric

“…Mucosal-associated invariant T (MAIT) cells have been implicated in various inflammatory diseases of barrier organs, but so far, their role in kidney disease…”
Get full text

SPARC expression in resected pancreatic cancer patients treated with gemcitabine: results from the CONKO-001 study by Sinn, M., Sinn, B.V., Striefler, J.K., Lindner, J.L., Stieler, J.M., Lohneis, P., Bischoff, S., Bläker, H., Pelzer, U., Bahra, M., Dietel, M., Dörken, B., Oettle, H., Riess, H., Denkert, C.

“…Previous investigations in pancreatic cancer suggested a prognostic role for secreted protein acidic and rich in cysteine (SPARC) expression in the peritumoral…”
Get full text

Derivation of normal pancreatic duct cells from human primary tissue and their stepwise genetic modification in vitro by Felsenstein, M., Hu, M., Delong Wood, L., Malinka, T., Bahra, M.

Get full text

Human equilibrative nucleoside transporter 1 expression analysed by the clone SP 120 rabbit antibody is not predictive in patients with pancreatic cancer treated with adjuvant gemcitabine – Results from the CONKO-001 trial by Sinn, M, Riess, H, Sinn, B.V, Stieler, J.M, Pelzer, U, Striefler, J.K, Oettle, H, Bahra, M, Denkert, C, Bläker, H, Lohneis, P

“…Abstract Background High expression of human equilibrative nucleoside transporter 1 (hENT1) is considered to predict survival in patients treated with adjuvant…”
Get full text

Clinical course and pancreas parenchyma sparing surgical treatment of severe pancreatic trauma by Chikhladze, S., Ruess, D.A., Schoenberger, J., Fichtner-Feigl, S., Pratschke, J., Hopt, U.T., Bahra, M., Wittel, U.A., Globke, B.

“…•Severe pancreatic trauma represents a major challenge for interdisciplinary trauma teams and management remains highly individualized.•Determination of main…”
Get full text

High expression of RelA/p65 is associated with activation of nuclear factor-κB-dependent signaling in pancreatic cancer and marks a patient population with poor prognosis by WEICHERT, W, BOEHM, M, NIESPOREK, S, JACOB, J, DIETEL, M, SCHEIDEREIT, C, KRISTIANSEN, G, GEKELER, V, BAHRA, M, LANGREHR, J, NEUHAUS, P, DENKERT, C, IMRE, G, WELLER, C, HOFMANN, H.-P

“…Activation of nuclear factor- κ B (NF- κ B) signaling was observed in pancreatic adenocarcinoma cell lines and tumours. However, information on the expression…”
Get full text

Independent validation and assay standardization of improved metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis by Mahajan, Ujjwal M., Oehrle, B., Sirtl, S., Alnatsha, A., Goni, E., Regel, I., Beyer, G., Vornhülz, M., Chromik, A., Bahra, M., Klein, F., Uhl, W., Fahlbusch, T., Distler, M., Weitz, J., Grützmann, R., Pilarsky, C., Weiss, F. Ulrich, Adam, G., Kalthoff, H., Rad, R., Christiansen, N., Bethan, B., Kamlage, B., Lerch, M.M., Mayerle, J.

Get full text

The Impact of Simultaneous Liver Resection for Occult Liver Metastases of Pancreatic Adenocarcinoma by Klein, Fritz, Puhl, Gero, Guckelberger, Olaf, Pelzer, Uwe, Pullankavumkal, J. R., Gül, Safak, Neuhaus, Peter, Bahra, Marcus

“…Backround. Pancreas resection is the only curative treatment for pancreatic adenocarcinoma. In the event of unexpected incidental liver metastases during…”
Get full text

Significant impact of patient age on outcome after liver resection for HCC in cirrhosis by Faber, W, Stockmann, M, Schirmer, C, Möllerarnd, A, Denecke, T, Bahra, M, Klein, F, Schott, E, Neuhaus, P, Seehofer, D

“…Abstract Objective Hepatocellular carcinoma (HCC) is one of the most common malignant tumors worldwide. The majority of patients with HCC have cirrhosis…”
Get full text

The Falciform Ligament for Mesenteric and Portal Vein Reconstruction in Local Advanced Pancreatic Tumor: A Surgical Guide and Single-Center Experience by Malinka, T., Klein, F., Denecke, T., Pelzer, U., Pratschke, J., Bahra, M.

“…Background. Since local tumor infiltration to the mesenteric-portal axis might represent a challenging assignment for curative intended resectability during…”
Get full text

Corrections to “SPARC expression in resected pancreatic cancer patients treated with Gemcitabine: results from the CONKO-001 study” by Sinn, M., Sinn, B.V., Striefler, J.K., Lindner, J.L., Stieler, J.M., Lohneis, P., Bischoff, S., Bläker, H., Pelzer, U., Bahra, M., Dietel, M., Dörken, B., Oettle, H., Riess, H., Denkert, C.

Get full text

332: Stem cell fractions of extra- and intrahepatic cholangiocellular carcinoma cell lines differ in size and phenotype by Schmuck, R, Fischer, C.V, Schirmeier, A, Neuhaus, P, Bahra, M

Get full text

SPARC expression in resected pancreatic cancer patients treated with Gemcitabine: results from the CONKO-001 study by Sinn, M, Sinn, B V, Striefler, J K, Lindner, J L, Stieler, J M, Lohneis, P, Bischoff, S, Bläker, H, Pelzer, U, Bahra, M, Dietel, M, Dörken, B, Oettle, H, Riess, H, Denkert, C

Get full text

Risk factors for 30‐day complications after cancer surgery in geriatric patients: a secondary analysis by Scholtz, K., Spies, C. D., Mörgeli, R., Eckardt, R., Dossow, V., Braun, S., Sehouli, J., Bahra, M., Stief, C. G., Wernecke, K.‐D., Schmidt, M., Weiß‐Gerlach, Edith, Al‐Hashem, Anwar, Brinkmann, Frederik, Collette, Anna‐Maria, Degel, Franziska, Beukelaer, Frederic, Geue, Susanne, Hartmann, Kerstin, Hennig, Saskia, Hoffmann, Inga, Mohr, Oskar, Petrov, Georgi

“…Background The aim was to analyse the association between severity of complications up to 30 days after surgery and pre‐operative nutritional and physical…”
Get full text

Management and outcomes of haemorrhage after pancreatogastrostomy versus pancreatojejunostomy by Eckardt, A. J., Klein, F., Adler, A., Veltzke-Schlieker, W., Warnick, P., Bahra, M., Wiedenmann, B., Neuhaus, P., Neumann, K., Glanemann, M.

“…Background: Postpancreatectomy haemorrhage (PPH) is a major cause of morbidity and mortality after pancreaticoduodenectomy (PD). It remains unclear whether…”
Get full text